← All MCC Flashcard Decks

Quality Control & Safety Standards Flashcards

9 cards from real MCC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 9 Quality Control & Safety Standards flashcards as text
  1. What is the primary purpose of quality control in medication compounding?

    Answer: To ensure medications are safe, potent, and pure

    The primary purpose of quality control in medication compounding is to rigorously verify that every compounded preparation meets specific standards for safety, potency, and purity. This involves testing and monitoring to ensure the medication contains the correct active ingredients in the right amounts, is free from contaminants, and will deliver the intended therapeutic effect. Ultimately, it safeguards patient health by preventing errors and ensuring product integrity.

  2. Why is environmental monitoring important in compounding facilities?

    Answer: To detect and prevent contamination risks

    Environmental monitoring in compounding facilities is crucial for regularly assessing the cleanliness and microbial load of the compounding environment, including air, surfaces, and personnel. This proactive measure helps detect potential sources of contamination early, allowing for corrective actions to prevent microbial ingress into compounded sterile preparations. By minimizing contamination risks, it directly ensures patient safety and the integrity of the medications.

  3. Which document is critical for ensuring consistency in compounded preparations?

    Answer: Master Formulation Record

    The Master Formulation Record is a critical document in compounding that provides a detailed, step-by-step recipe and procedure for preparing a specific compounded medication. It ensures consistency and reproducibility by outlining all ingredients, quantities, compounding methods, equipment, and quality control checks. This guarantees that each batch is prepared identically and meets quality standards, which is vital for patient safety and therapeutic efficacy.

  4. What is a major consequence of improper labeling of compounded medications?

    Answer: Potential patient harm and legal risks

    Improper labeling of compounded medications is a serious issue that can lead to significant patient harm, including incorrect dosing, administration of the wrong medication, or adverse drug reactions. Such errors also expose the compounding pharmacy to substantial legal risks, including liability lawsuits and regulatory penalties, due to negligence and failure to ensure patient safety. Clear and accurate labeling is therefore paramount for patient well-being and legal compliance.

  5. How often should personnel competency be reassessed in sterile compounding?

    Answer: Annually

    In sterile compounding, personnel competency must be reassessed annually to ensure that all individuals involved maintain the necessary skills and knowledge to prepare sterile products safely and effectively. This regular evaluation, often including media-fill tests and observation of aseptic technique, is crucial for preventing contamination and ensuring patient safety in sterile preparations. It upholds the highest standards of practice and minimizes risks.

  6. Which standard guides sterile compounding practices?

    Answer: USP

    USP is the official standard from the United States Pharmacopeia that provides comprehensive guidelines for the compounding of sterile preparations. This standard outlines requirements for facilities, personnel training, environmental monitoring, and quality assurance to minimize the risk of contamination. Adherence to USP ensures the sterility, purity, and potency of compounded sterile products, thereby protecting patient safety.

  7. What is the main goal of safety standards in medication compounding?

    Answer: To ensure the safety of patients and compounding personnel

    The main goal of safety standards in medication compounding is paramount: to protect both the patients receiving the compounded medications and the personnel involved in their preparation. These standards establish rigorous protocols for handling hazardous materials, maintaining sterile environments, ensuring accurate dosing, and preventing contamination. All these measures are critical for preventing harm and ensuring overall well-being in the compounding process.

  8. What type of gowning material is preferred in sterile compounding?

    Answer: Non-shedding sterile materials

    In sterile compounding, the primary goal is to prevent contamination of the compounded sterile product. Non-shedding sterile materials are crucial because they minimize the release of particulate matter, such as fibers or skin cells, into the cleanroom environment. This helps maintain the required air quality and sterility, protecting the patient from potential infections or adverse reactions caused by contaminants.

  9. Why must Beyond-Use Dates (BUDs) be assigned to compounded medications?

    Answer: To ensure medication strength, quality, and purity

    Beyond-Use Dates (BUDs) are assigned to compounded medications to define the period during which a preparation can be used, ensuring it retains its intended strength, quality, and purity. Unlike expiration dates for manufactured products, BUDs are determined based on stability studies, formulation characteristics, and storage conditions. This practice is critical for patient safety, as using a medication past its BUD could result in reduced efficacy or increased risk of degradation products.